Ley­den Labs gets $70M to test if nasal sprays can help pro­tect against virus­es

A Dutch biotech cre­at­ing nasal sprays to pro­tect against the flu and coro­n­avirus has raised an ad­di­tion­al $70 mil­lion and ac­quired a nim­ble Sin­ga­pore start­up …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER